Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery
Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery
Olaparib slows growth of BRCA-related metastatic breast cancer
Web-based system for self-reporting symptoms may help patients live longer
3 or 6 months adjuvant oxaliplatin for colorectal cancer
No link between pregnancy and breast cancer relapse
Cancer and caring in modern medicine
Pooled analysis of avelumab for metastatic urothelial carcinoma
Cancer and living meaningfully: the CALM intervention
'Conquer Fear' of disease recurrence
Screening for 508 genes in liquid biopsy to chart cancer evolution
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Routine genomic testing is feasible, but only a subset of patients benefit